Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Objective To conduct a systematic review to determine the relative effectiveness of
treatments currently employed in the management of superior vena caval obstruction …

Malignancy is the most common cause of the superior vena cava (SVC) syndrome. With the
increasing use of intravascular devices, the incidence of the SVC syndrome arising from …

Superior vena cava syndrome (SVCS) is a relatively common sequela of mediastinal
malignancies and may cause significant patient distress. SVCS is a medical emergency if …

Objectives: To provide an up-to-date review of current literature on the pathophysiology,
diagnosis, and management of five key malignancy-related complications: superior vena …

Background Superior vena caval obstruction (SVCO) is an uncommon manifestation of
carcinoma of the bronchus characterised by neck swelling and distended veins over the …

Superior vena cava syndrome is referred to as a constellation of symptoms and signs
caused by obstruction of superior vena cava. It can occur due to both benign and malignant …

Lung cancer is the second most common cancer in the United States, and small cell lung
cancer (SCLC) accounts for about 15% of all lung cancers. In SCLC, more than other …

Objective: Since some malignancies causing superior vena cava syndrome (SVCS) are only
sensitive to a specific treatment regimen, it is crucial to diagnose the underlying pathology in …

PURPOSE: To predict the long-term survival results of clinical trials earlier than using
actuarial methods and to assess the factors predictive of long-term cure in patients with …